Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
View Full LandscapeTarget Indication
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
Clinical Trial
NCT07429240Last updated: 5/1/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Major Depressive Disorder
Epileptic Encephalopathy
SCN2A Encephalopathy
Focal Seizure
Developmental and Epileptic Encephalopathy 1